Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Peptides: The growing W E L L N E S S trend that everyone is talking about! You may have heard about BPC 157 and GHK Cu two peptides gaining attention in BPC 157 Peptide Therapy New Results Medical Weight Loss Subcutaneous Injection: What It Is and How to Give One